Meningitis Vaccine
Overview
Meningitis Vaccine is a sterile lyophilized extract of the group specified polysaccharide capsular antigens from Neiseria meningitidis. Meningitis Vaccine is used to provide active immunisation (protection) against meningitis. Meningitis Vaccine is recommended for children 2 years of age and older and adults at risk in epidemic and highly endemic areas .
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Back to top
Back to top
Side Effects
The symptomatic adverse reactions produced by Meningitis Vaccine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Fatigue, Fever, Erythema, Allergic reactions.
Back to top
Dosage
Meningitis Vaccine's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.5 ml | 0.5 (0.5) | As recommended. | SC | Same dose for children above 2 months of age and Adults. |
Paedriatic Dosage (20kg)
|
| 0.5 ml | 0.5 (0.5) | As recommended. | Subcutaneous | For once, or as required |
Neonatal Dosage (3kg)
|
| 0.5 ml | 0.5 (0.5) | As recommended. | Subcutaneous | For once or as required .For over 2 month of child |
High Risk Groups
Back to top
Warning / Precautions
Vaccination should be postponed in patients suffering from any acute illness. Immunization should not be carried out in individuals who have previously had a severe local or general reaction to the vaccine. Some vaccine contains antibiotics in small amount and should not be given to patients with history of anaphylaxis to the agent used.
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Meningitis Vaccine
Click on the desired strength of the dosage form to view its available brands.
Single Ingredient
Inj: 50 mcg/0.5ml, 200 mcg/0.5ml,
Back to top
Manufacturers of
Meningitis Vaccine
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic